Condensed Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Public Stock Offering	Private Placement	Pre-Funded Warrants Private Placement	Common Stock	Common Stock Public Stock Offering	Common Stock Private Placement	Additional Paid-in Capital	Additional Paid-in Capital Public Stock Offering	Additional Paid-in Capital Private Placement	Additional Paid-in Capital Pre-Funded Warrants Private Placement	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022					69,768
Beginning balance at Dec. 31, 2022	$ 578,075				$ 7			$ 939,310				$ (2,698)	$ (358,544)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)					102
Issuance of common stock upon exercise of stock options	520							520
Issuance of common stock, net of issuance costs (in shares)						943
Issuance of common stock, net of issuance costs		$ 22,441							$ 22,441
Stock-based compensation	9,104							9,104
Net loss	(52,394)												(52,394)
Other comprehensive income (loss)	1,169											1,169
Ending balance (in shares) at Mar. 31, 2023					70,813
Ending balance at Mar. 31, 2023	$ 558,915				$ 7			971,375				(1,529)	(410,938)
Beginning balance (in shares) at Dec. 31, 2023	79,275				79,275
Beginning balance at Dec. 31, 2023	$ 500,764				$ 8			1,071,395				125	(570,764)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	541				541
Issuance of common stock upon exercise of stock options	$ 3,896							3,896
Issuance of common stock, net of issuance costs (in shares)						418	15,225
Issuance of common stock, net of issuance costs		$ 5,594	$ 238,388	$ 141,395			$ 2		$ 5,594	$ 238,386	$ 141,395
Issuance of common stock in connection with vesting of restricted stock units (in shares)					135
Stock-based compensation	10,306							10,306
Net loss	(68,855)												(68,855)
Other comprehensive income (loss)	$ (589)											(589)
Ending balance (in shares) at Mar. 31, 2024	95,594				95,594
Ending balance at Mar. 31, 2024	$ 830,899				$ 10			$ 1,470,972				$ (464)	$ (639,619)